Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer

NCT06195228 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT06195228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06195228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer
Lead sponsor
Fudan University
Phase
Phase 4
Overall status
Recruiting
Start date
January 1, 2020
Completion date
December 31, 2028
Enrollment
800 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

advanced thyroid cancer patients who received target therapy